Atlas Trials

BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies

Clinical trial NCT03269175 · COMPLETED

Trial details

NCT number
NCT03269175
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2017-09-29
Primary completion
2018-05-24
Enrollment
261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.